VivoSeq
Other

Tobacco Use

0

Pipeline Programs

7

Active Trials

0

Companies Involved

Tobacco Use is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

14

clinical trials

Completed7 · 50%
Recruiting3 · 21%
Active, not recruiting3 · 21%
Not yet recruiting1 · 7%

Trial Activity

14 trials

Optimizing Tobacco Use Treatment for PLWHA
Recruiting·UUniversity of Pennsylvania·Phase 3·NCT04176172·340 enrolled
Varenicline for Co-occurring Cannabis and Tobacco Use
Completed··Phase 4·NCT04595318·7 enrolled
Advancing Tobacco Use Treatment for African American Smokers
Completed··Phase 4·NCT02360631·500 enrolled
Tobacco Use Treatment in Cancer Patients
Completed·UUniversity of Florida·Phase 4·NCT03482583·90 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)